The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections.

The present disclosure relates to an apparatus for flexographic printing of a web of packaging material with printing ink and an inlet module for a flexographic printing apparatus. The apparatus may include an ink pan or chamber, and an anilox roll rotary at least partly inside the ink chamber for picking up and transferring printing ink from the ink chamber to an impression cylinder which is rotary in transfer contact with the anilox roll. The ink chamber may be elongated and extend axially along the anilox roll, the ink chamber having a first axial end and a second axial end opposite the first axial end. The apparatus may further include a first printing ink inlet arranged at the first axial end and a second printing ink inlet arranged at the second axial end.

The present disclosure relates to an apparatus for flexographic printing of a web of packaging material with printing ink and an inlet module for a flexographic printing apparatus. The apparatus may include an ink pan or chamber, and an anilox roll rotary at least partly inside the ink chamber for picking up and transferring printing ink from the ink chamber to an impression cylinder which is rotary in transfer contact with the anilox roll. The ink chamber may be elongated and extend axially along the anilox roll, the ink chamber having a first axial end and a second axial end opposite the first axial end. The apparatus may further include a first printing ink inlet arranged at the first axial end and a second printing ink inlet arranged at the second axial end.

A composition for producing particulate coatings for printing machine cylinders or printing machine cylinder covers that are nonstick and wear resistant. The composition includes at least one sol-gel precursor compound and a mixture of hard solid-state particles, such as silicon carbide. One type of particles has a Sauter diameter d.sub.32 of between 1.0 ?m and 2.0 ?m and the other type of less than 1.0 ?m. A mixing ratio of the two types of hard solid-state particles lies in the range from 1.5:1 to 1:1.5.

A processing unit for rotational processing includes at least two processing cylinders and a machine frame. A first processing cylinder is movably mounted in the machine frame, a second processing cylinder is stationarily mounted in the machine frame and a pair of support members is provided for each respective processing cylinder. A respective support member of the second processing cylinder has a solid joint, a manipulator and an annular segment attached to the solid joint and contacting one support member of the first processing cylinder. A solid joint is linearly displaceable by the manipulator and an annular segment is linearly displaceable therewith. A gap dimension between the processing cylinders can therefore be adjusted in a simple, accurate manner with precise repeatability. A label printing machine having the processing unit is also provided.

A processing unit for rotational processing includes at least two processing cylinders and a machine frame. A first processing cylinder is movably mounted in the machine frame, a second processing cylinder is stationarily mounted in the machine frame and a pair of support members is provided for each respective processing cylinder. A respective support member of the second processing cylinder has a solid joint, a manipulator and an annular segment attached to the solid joint and contacting one support member of the first processing cylinder. A solid joint is linearly displaceable by the manipulator and an annular segment is linearly displaceable therewith. A gap dimension between the processing cylinders can therefore be adjusted in a simple, accurate manner with precise repeatability. A label printing machine having the processing unit is also provided.

The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections

The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections

The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections.

The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections.